PDCD1 and asthenia: The most commonly reported drug-related TEAEs included decreased white blood cell count, asthenia, rash, hypothyroidism, and decreased neutrophil count, which have been reported for other PD-1/PD-L1 inhibitors [13, 15, 25, 26].